COVID-19: Breakthrough Treatment Claims to Stop 100% of Symptomatic Infections
The makers of an experimental drug, now being trialed by the NHS, say it is 100 per cent effective in protecting against symptomatic cases of the virus. US-based Regeneron Pharmaceuticals says its two-antibody cocktail called REGEN-COV also reduces overall coronavirus infection rates by about 50 per cent.
Photo Credit: Myriam Zilles